HomeCompareBAYRY vs XYLD

BAYRY vs XYLD: Dividend Comparison 2026

BAYRY yields 0.26% · XYLD yields 10.93%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XYLD wins by $5.4K in total portfolio value
10 years
BAYRY
BAYRY
● Live price
0.26%
Share price
$11.48
Annual div
$0.03
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.03
Full BAYRY calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.93%
Share price
$39.31
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$3,189.45
Full XYLD calculator →

Portfolio growth — BAYRY vs XYLD

📍 XYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAYRYXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAYRY + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAYRY pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAYRY
Annual income on $10K today (after 15% tax)
$22.21/yr
After 10yr DRIP, annual income (after tax)
$0.03/yr
XYLD
Annual income on $10K today (after 15% tax)
$929.36/yr
After 10yr DRIP, annual income (after tax)
$2,711.03/yr
At 15% tax rate, XYLD beats the other by $2,711.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAYRY + XYLD for your $10,000?

BAYRY: 50%XYLD: 50%
100% XYLD50/50100% BAYRY
Portfolio after 10yr
$22.4K
Annual income
$1,594.73/yr
Blended yield
7.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BAYRY right now

BAYRY
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
0.9
Piotroski
5/9
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAYRY buys
14
XYLD buys
0
PoliticianChamberTickerTypeAmountDate
Michael McCaul🏢 House$BAYRY▼ Sell$50,001 - $100,0002025-01-09
Michael McCaul🏢 House$BAYRY▼ Sell$50,001 - $100,0002024-11-19
Michael McCaul🏢 House$BAYRY▼ Sell$15,001 - $50,0002024-08-27
Michael McCaul🏢 House$BAYRY▲ Buy$15,001 - $50,0002024-08-02
Michael McCaul🏢 House$BAYRY▲ Buy$15,001 - $50,0002024-06-06
Michael McCaul🏢 House$BAYRY▲ Buy$15,001 - $50,0002024-06-06
Michael McCaul🏢 House$BAYRY▲ Buy$15,001 - $50,0002024-05-20
Michael McCaul🏢 House$BAYRY▲ Buy$15,001 - $50,0002024-05-20
Michael McCaul🏢 House$BAYRY▲ Buy$15,001 - $50,0002024-05-02
Michael McCaul🏢 House$BAYRY▲ Buy$15,001 - $50,0002024-05-02
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAYRYXYLD
Forward yield0.26%10.93%
Annual dividend / share$0.03$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$19.7K$25.1K
Annual income after 10y$0.03$3,189.45
Total dividends collected$26.00$19.4K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: BAYRY vs XYLD ($10,000, DRIP)

YearBAYRY PortfolioBAYRY Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$10,713$13.07$10,813$1,093.36$100.00XYLD
2$11,470$6.54$11,727$1,216.35$257.00XYLD
3$12,276$3.27$12,756$1,357.11$480.00XYLD
4$13,137$1.64$13,917$1,518.69$780.00XYLD
5$14,057$0.82$15,232$1,704.71$1.2KXYLD
6$15,041$0.41$16,725$1,919.54$1.7KXYLD
7$16,094$0.20$18,425$2,168.40$2.3KXYLD
8$17,221$0.10$20,367$2,457.63$3.1KXYLD
9$18,427$0.05$22,592$2,794.87$4.2KXYLD
10$19,717$0.03$25,149$3,189.45$5.4KXYLD

BAYRY vs XYLD: Complete Analysis 2026

BAYRYStock

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Full BAYRY Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this BAYRY vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAYRY vs SCHDBAYRY vs JEPIBAYRY vs OBAYRY vs KOBAYRY vs MAINBAYRY vs QYLDBAYRY vs JEPQBAYRY vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.